Listar por autor "Janjigian, Yelena"
Mostrando ítems 1-3 de 3
-
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
Tabernero Caturla, Josep; Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles; Janjigian, Yelena; Bhagia, Pooja (Future Medicine, 2021-08) -
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
Janjigian, Yelena; Van Cutsem, Eric; Muro, Kei; Wainberg, Zev; Al-Batran, Salah-Eddin; Hyung, Woo Jin; Tabernero Caturla, Josep (Future Medicine, 2022-06) -
Quality of life with first-line pembrolizumab for PD-L1–positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
Van Cutsem, Eric; Valderrama, A.; Bang, Yung-Jue; Fuchs, Charles; Shitara, Kohei; Janjigian, Yelena; Alsina Maqueda, Maria (Elsevier, 2021-08)